Evidence map›Paper›PMID 30015395›Full record

ArticleESC heart failure2018

Diagnosing and grading heart failure with tomographic perfusion lung scintigraphy: validation with right heart catheterization.

Jonas Jögi, Mariam Al-Mashat, Göran Rådegran, Marika Bajc, Håkan Arheden

Open access · goldAbstract read
In one paragraph

Article in ESC heart failure, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jonas JögiDepartment of Clinical Sciences Lund, Department of Clinical Physiology, Lund University, Skåne University Hospital, Lund, Sweden.ORCID 0000-0002-5299-3628
Mariam Al-MashatDepartment of Clinical Sciences Lund, Department of Clinical Physiology, Lund University, Skåne University Hospital, Lund, Sweden.
Göran RådegranDepartment of Clinical Sciences Lund, Department of Cardiology, Heart and Lung Medicine, Lund University, Skåne University Hospital, Lund, Sweden.
Marika BajcDepartment of Clinical Sciences Lund, Department of Clinical Physiology, Lund University, Skåne University Hospital, Lund, Sweden.
Håkan ArhedenDepartment of Clinical Sciences Lund, Department of Clinical Physiology, Lund University, Skåne University Hospital, Lund, Sweden.
Lund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsPulmonary congestion remains a diagnostic challenge in patients with heart failure (HF). The recommended method, chest X-ray (CXR), lacks in accuracy, whereas quantitative tomographic lung scintigraphy [ventilation/perfusion single-photon emission computed tomography (V/P SPECT)] has shown promising results but needs independent validation. The aim of this study is to evaluate V/P SPECT as a non-invasive method to assess and quantify pulmonary congestion in HF patients, using right heart catheterization as reference method. The secondary objective was to investigate the performance of V/P SPECT in the clinical setting compared with CXR. METHODS AND

resultsForty-six consecutive patients with HF that were under consideration for heart transplantation were studied prospectively. All participants were examined with V/P SPECT, CXR, and right heart catheterization. Pulmonary artery wedge pressure served as reference method. Quantitative perfusion gradients were derived from V/P SPECT images. Ventilation/perfusion single-photon emission computed tomography images were also assessed both by expert readers and clinical nuclear medicine physicians. Expert readers correctly identified 87% of all patients with an elevated pulmonary artery wedge pressure > 15 mmHg. The average sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for V/P SPECT assessed by the expert readers were 87%, 72%, 85%, and 75%, respectively. In the clinical nuclear medicine setting, V/P SPECT had 87% sensitivity, 63% specificity, 81% PPV, and 71% NPV. Clinically, V/P SPECT outperformed CXR, which had 27% sensitivity, 75% specificity, 67% PPV, and 35% NPV.

conclusionsVentilation/perfusion single-photon emission computed tomography can be used as a non-invasive method to diagnose and quantify pulmonary congestion in patients with HF and is more accurate than CXR in diagnosing pulmonary congestion in the clinical setting.

Indexed as

Cardiac CatheterizationFemaleFollow-Up StudiesHeart FailureHeart VentriclesHumansLungMaleMiddle AgedPerfusion ImagingProspective StudiesReproducibility of ResultsSeverity of Illness IndexTime FactorsTomography, Emission-Computed, Single-PhotonVentilation-Perfusion RatioHeart failureLung scintigraphyPulmonary congestionPulmonary perfusion distributionRight heart catheterizationV/P SPECT

Identifiers

PMID30015395
PMCPMC6165926
OpenAlexW2883689650

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.